Research & Development
Pathology & AI
Biomarker Discovery & Validation
Biocare Medical acquires Empire Genomics to expand molecular biomarker portfolio
The acquisition of Empire Genomics will expand Biocare Medical’s molecular biomarker portfolio substantially.
November 22, 2022
Universal Diagnostics study assesses methylation biomarkers' role in early colorectal cancer
The company will present the findings at the AACR Special Conference on Precisions, Prevention, Early Detection, and Interception of Cancer being held in Austin, TX, November 17-19.
November 17, 2022
Mainz Biomed initiates U.S. extension of colorectal cancer study to evaluate mRNA biomarkers
Mainz Biomed announced an extension of its ColoFuture European study, which aims to evaluate the use of mRNA biomarkers for the early detection of colorectal cancer.
November 15, 2022
Akoya Biosciences launches panels for spatial biomarker discovery and validation
The PhenoCode Signature Panels are a hybrid of the company’s legacy Codex and Opal assays, and, when combined with the PhenoImager platforms, enable spatial phenotyping workflow, Akoya said.
November 8, 2022
QMC Health, Lawson Health Research ink agreement for long-COVID blood biomarkers
With blood biomarkers acquired in an agreement with Lawson Health Research Institute, QMC Health plans to develop a point-of-care rapid test using its QDX HPFIS technology.
November 1, 2022
Quest Diagnostics, Decode Health expand collaboration on biomarker discovery to MS, NAFLD
At this stage of the collaboration, the companies will focus on early detection, differential diagnosis, and therapy selection for multiple sclerosis (MS) and nonalcoholic fatty liver disease (NAFLD).
October 18, 2022
DNA forensic evidence frees Ohio man of rape, attempted rape
Low-value prostate cancer screening has Medicare spending ramifications, study finds
‘Good’ cholesterol worse for some adults: NIH study
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
PerkinElmer launches adeno-associated virus vector detection kits for research
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
Renalytix to present at American Society of Nephrology Kidney Week
The presentations will include a cost-effectiveness analysis supporting population-based KidneyIntelX testing for Medicare patients, as well as findings from a multiyear study at a major healthcare system highlighting disparities in healthcare access.
October 17, 2022
Oni, University of Pennsylvania to collaborate on CAR-T therapy research
Oni's Nanoimager super-resolution microscopy will allow researchers to visualize living cells and observe how single molecules interact.
October 11, 2022
Bio-Techne releases automated codetection assays for Roche platform
Developed in partnership with Roche, the new automated multiomic assays use Bio-Techne's patented RNAscope and BaseScope signal amplification and background suppression technologies.
October 6, 2022
Qiagen, Neuron23 to develop CDx for Parkinson’s
Under the agreement, Qiagen will develop and validate a clinical trial assay that will detect a combination of biomarkers discovered by Neuron23 that together predict the responsiveness of Parkinson's disease to a LRRK2 inhibitor.
September 13, 2022
Nucleai, Sirona Dx partner on tumor biomarker discovery
The partnership combines Nucleai's artificial intelligence (AI) spatial analytics platform with Sirona Dx's multiplex assay development expertise to identify novel spatial signatures in high-plex assays that predict responses to therapy and inform treatment decisions.
July 13, 2022
Boehringer Ingelheim, BiomX partner on IBD biomarkers
BiomX said that under the collaboration, it will utilize its XMarker microbiome-based biomarker discovery platform with the goal of identifying biomarkers for a pathogenic bacterium thought to be associated with IBD.
June 27, 2022
Page 1 of 3